enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. Largest-ever Ozempic and GLP-1 drug study finds they lower ...

    www.aol.com/finance/largest-ever-ozempic-glp-1...

    Studies have shown that a GLP-1 drug, exenatide, sufficiently crosses the blood-brain barrier in rodent models of Parkinson’s disease, leading to improvements in motor performance, behavior ...

  3. Semaglutide Side Effects: Is It Safe? What You Need To Know - AOL

    www.aol.com/semaglutide-side-effects-safe-know...

    How Semaglutide Works. Semaglutide is in a class called glucagon-like peptide-1 (GLP-1) receptor agonists. It works by mimicking GLP-1, a hormone the intestines naturally make.. GLP-1 plays a key ...

  4. Weight-loss, diabetes drugs linked to vision problems in ...

    www.aol.com/news/weight-loss-diabetes-drugs...

    Glucagon-like peptide 1 (GLP-1) receptor agonists, which are used to treat type 2 diabetes and/or obesity, were linked to vision problems in a small study at the University of British Columbia.

  5. GLP-1 receptor agonist - Wikipedia

    en.wikipedia.org/wiki/GLP-1_receptor_agonist

    Native GLP-1 is a peptide hormone with a half-life of two minutes because it is rapidly cleared by the enzyme dipeptidyl peptidase-4. [29] As a result, different GLP-1 agonist drugs are modified in various ways to extend the half-life, resulting in drugs that can be dosed multiple times per day, daily, weekly, or less often. [29]

  6. Anti-obesity medication - Wikipedia

    en.wikipedia.org/wiki/Anti-obesity_medication

    GLP-1 agonists such as tirzepatide, semaglutide, and liraglutide slow gastric emptying and also have neurologically driven effects on appetite. [14] It is unknown if GLP-1 agonists or dual/triple agonists of GLP-1 and/or the glucagon or GIP receptors act solely by reducing energy intake or if they also increase energy expenditure. [15]

  7. Cagrilintide/semaglutide - Wikipedia

    en.wikipedia.org/wiki/Cagrilintide/semaglutide

    In December 2024, Novo Nordisk announced the results of REDEFINE 1, one of their series of Phase III trials, testing weekly cagrilintide 2.4 mg and semaglutide 2.4 mg individually and together versus placebo in obese or overweight subjects with one or more comorbidities. [7]

  8. Ozempic shown to reduce drinking in first trial in alcohol ...

    www.aol.com/news/ozempic-shown-reduce-drinking...

    Semaglutide, sold by Novo Nordisk as Ozempic for type 2 diabetes and Wegovy for obesity, is part of a class of drugs known as GLP-1 receptor agonists, mimicking the hormone GLP-1 to reduce ...

  9. Semaglutide - Wikipedia

    en.wikipedia.org/wiki/Semaglutide

    [23] [24] [25] It is a peptide similar to the hormone glucagon-like peptide-1 (GLP-1), modified with a side chain. [ 26 ] [ 27 ] It can be administered by subcutaneous injection or taken orally . [ 14 ] [ 15 ] [ 16 ] [ 28 ] It is sold by Novo Nordisk under the brand names Ozempic [ 14 ] and Rybelsus [ 15 ] for diabetes, and under the brand name ...